September 13, 2018 06:48 AM EDT
People
China

Sanofi swaps top ex­ecs with Bay­er, trig­ger­ing a re­or­ga­ni­za­tion that puts Chi­na in the head­lights

John Carroll

Editor & Founder

Sanofi and Bay­er are swap­ping out two top ex­ecs, trig­ger­ing a re­or­ga­ni­za­tion at the French phar­ma com­pa­ny that will al­low for a clos­er fo­cus on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times